WENA (Anew Medical, Inc.) Net Profit

Anew Medical, Inc. (WENA) is optimizing the logistics of clinical trials for neurological drugs through a network of laboratories, relying on a compact staff of scientists and external contractors. The dynamics of the company's bottom line on the current GURU.Markets platform chart reflect current trends, where 0.00 expresses the latest metric level. The issuer's growth is based on gene therapy for ALS and Alzheimer's, as well as a strategic partnership with Big Pharma.

WENA - Anew Medical Net Profit over the range 06/25/2024 - 09/17/2024

Comprehensive metric breakdowns and analytics for Anew Medical (WENA)

- stock value and consensus price forecast:
Market Price anewmeds.com|WENA - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Anew Medical, Inc.|WENA - Total Company Value
- book capitalization data:
Equity per Share Anew Medical|WENA - Book Capitalization|Market-to-Book Ratio anewmeds.com|WENA - Cumulative Company Assets
- debt and liquidity details:
Total Debt to Equity Ratio Anew Medical, Inc.|WENA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Anew Medical Inc.|WENA - Company Debts|Debt to Book Value Anew Medical, Inc.|WENA - Company Long-Term Debts|Short-Term Debt Anew Medical|Immediate Liquidity Ratio anewmeds.com
- earnings and market ratios statistics:
WENA - Net Profit
Basic company analysis:WENA, anewmeds.com

Investors assess business resilience through net income trends, calculated as the remaining revenue after deducting all operating and tax expenses. For Anew Medical, Inc. (WENA), which invests in gene therapy for ALS and Alzheimer's disease, this metric reflects the efficiency of monetizing R&D developments, as clearly evidenced by an analysis of the company's marginal income.

Direct competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Profit regencellbioscience.com|Company Net Income Axsome Therapeutics, Inc. (AXSM)|ACADIA Pharma - Company Profit|Net Profit XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Company Net Income|SUPN: Net Income|catalystpharma.com (CPRX) - Net Income|DNLI (Denali Therapeutics Inc.) - Net Income|Harmony Biosciences Inc - Final Profit|Company Net Income Biohaven Pharmaceutical|Net Income Amylyx Corp (AMLX)|Net Profit TRVI|PRAX - Company Net Income|Net Profit AVXL (Anavex Life Sciences Corp.)|CBLL: Company Profit|Prothena Biosciences - Net Profit|Net Financial Result Alector, Inc. ALEC|ANNX: Net Profit|Net Income Omeros|NGNE (Neurogene) - Net Profit|Net Profit AC Immune S.A.|Company Net Income Voyager Pharma (VYGR)|Company Net Income NMRA (Neumora Corp)|Scilex Holding Company - Net Income|Final Profit TVGN|Alpha Cognition Corp - Net Profit|Net Financial Result cogrx.com CGTX|Inhibikase (IKT) - Company Net Income|Company Profit SAVA|ASRT (Assertio Holdings) - Net Profit|Net Income Coya (COYA)|Net Income VTGN (Vistagen Therapeutics)|Net Financial Result ovidrx.com|Acumen Pharma - Net Income|CRVO - Net Income|Alterity Therapeutics Ltd - Net Profit|Company Net Income Clene Inc.|pepgen.com (PEPG) - Company Net Income|Company Profit JUNS|RLMD (Relmada) - Net Profit|Net Profit Annovis Bio Corporation|Company Net Income Grace Therapeutics, Inc. (GRCE)|fireflyneuro.com - Company Profit|Net Profit KLTO (Klotho Neurosciences)|NeuroSense Therapeutics Ltd (NRSN) - Company Net Income|RVPH: Net Income|MTVA - Net Profit|NeurAxis, Inc. (NRXS) - Company Net Income|Helius Medical Technologies - Final Profit|Company Net Income Passage Bio Inc.|Company Net Income Neuphoria NEUP|Net Profit NERV|Net Profit Athira Pharma Corp (ATHA)|Company Net Income Addex Therapeutics ADXN|ALZN: Company Profit|Cyclerion - Net Profit|Company Net Income Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Net Income|Net Income Cortigent|Net Income ATXI|BCLI: Final Profit|Company Net Income Cara Therapeutics (CARA)|Net Income Chromocell Therapeutics Corp CHRO|Net Profit ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Company Net Income|Longboard Pharmaceuticals - Net Profit|MRNS (marinuspharma.com) - Company Profit|NKGN: Net Profit|NRBO - Net Financial Result|SAGE (Sage Therapeutics, Inc) - Net Profit|Net Income Synaptogenix, Inc (SNPX)|Net Profit TRVN|Net Profit vigilneuro.com (VIGL)|Company Net Income Cerevel Therapeutics, Inc. CERE